| anxiolytic |
phenotype |
2 |
2 |
|
| anxiolytic effect |
phenotype |
8 |
4 |
anxiolytic, anxiolytic effect |
| anxiousness |
phenotype |
2 |
2 |
|
| any substance use |
phenotype |
3 |
1 |
any use, indicator of any substance use |
| any substance use disorder |
phenotype |
2 |
2 |
|
| AP |
drug |
3 |
53 |
Alcohol Problems, alcohol problems |
| AP-1 |
drug |
2 |
— |
FOS/JUN |
| AP-2 |
drug |
2 |
2 |
AP2, AP‑2, Adaptor protein complex 2, adaptor complex (AP), adaptor complex 2, adaptor protein complex 2 |
| APC |
drug |
2 |
2 |
|
| APOC3 |
gene |
2 |
2 |
Apolipoprotein C-III |
| APOC4 |
gene |
2 |
— |
|
| apoE |
gene |
25 |
17 |
APOE, APOE susceptibility gene, APOE ε4, APOE-4, APOE-4 allele, ApoE, Apolipoprotein E, apoE, apoE4/4, apolipoprotein E, apolipoprotein E APOE |
| apoE4 |
gene |
3 |
2 |
APOE ε4, ApoE4/4, apoE4, apoE4/4 genotype, apolipoprotein E epsilon 4 allele |
| APOE-4 carriers |
cohort |
2 |
2 |
|
| APOE ε4 |
gene |
5 |
4 |
APOE ε4 risk allele, APOE4, ApoE ε4, allele 4, apoE4, ε4, ε4 allele |
| APOE-ε4 |
gene |
3 |
1 |
APOE-4, APOE-ε4 allele, apoE4, epsilon 4 allele |
| APOE ε4 allele |
gene |
3 |
3 |
APOE*ε4, APOE-4, ApoE 4 allele, ε4, ε4 allele |
| apomorphine |
drug |
2 |
1 |
|
| apoptosis |
phenotype |
31 |
19 |
OPC death, apoptosis, cell death, natural apoptosis, oligodendrocyte death |
| APP |
gene |
15 |
14 |
APP, Amyloid precursor protein, Aβ precursor protein, amyloid precursor protein, human APP, soluble APP |
